Pancreatic Cancer Research

ResearcherUniversitat Autònoma de BarcelonaNo recent work listed

Toni Jauset Gonzalez

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2869-5804; OpenAlex author ID A5078021547. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC. Co-author DOI 10.18632/oncotarget.24648↗
  2. Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma. First author DOI 10.1158/0008-5472.can-14-2852↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel Massó-Vallés · 2 shared papers, 2015–2018 · strength 0.12
  2. Laura Soucek · 2 shared papers, 2015–2018 · strength 0.12
  3. Kim Pedersen · 1 shared paper, 2015 · strength 0.05
  4. Nicole M. Sodir · 1 shared paper, 2015 · strength 0.05
  5. Gérard I. Evan · 1 shared paper, 2015 · strength 0.05
  6. Joaquı́n Arribas · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.